Price History
Feb 9, 2026 — Aug 12, 2026Investment Snapshot
- Trading 15% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 20.5% — good return on equity
Pediatrix Medical Group, Inc. Common Stock (MD) is a Healthcare company operating in Services-Hospitals, listed on the NYSE , with a market capitalisation of $2.2 billion . Key value metrics: P/E ratio 12.1, P/B ratio 2.47, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Pediatrix Medical Group, Inc. Common Stock — Fundamental Analysis Summary
Pediatrix Medical Group, Inc. Common Stock (MD) is currently trading 15% above its Graham Number of $23.27, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 12.1x.
On financial health, MD shows a moderate Piotroski F-Score of 5/9, and strong return on equity of 20.5% (sector average: -20.1%), and manageable leverage with a debt-to-equity ratio of 0.68.
StockPik's composite Value Score for MD is 87/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MD shows earnings growing at 267%.